Why the study?
Does continuation of warfarin therapy increase bleeding complications in patients undergoing cutaneous surgery?
Population
1,090 patients undergoing cutaneous surgery, from which 16 patients treated with warfarin and 77 control…
Comparison
Continuation of warfarin therapy with… vs Control group of 77 patients undergoing…
Design
Cohort
Authors
Loading...
Warfarin continuation was associated with minimal bleeding in cutaneous surgery; hypothesis-generating and requires RCTs before practice change.
Does continuation of warfarin therapy increase bleeding complications in patients undergoing cutaneous surgery?
Continuing warfarin therapy during cutaneous surgery appears safe and does not increase postoperative bleeding, thereby avoiding the risk of thromboembolic events associated with its discontinuation.
Joseph Alcalay (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: